+
Home
About
Letter from the President
Leadership
Leadership
Past Leadership
Mission and Goals
The History of CGC
CGC News
Privacy Policy
Membership
Become a Member
Working Groups
Committees
Member Login
Support the CGC
Resources
Cancer Genetics Journal
CGC Publications
CGC Policies and Procedures
Compendium of Cancer Genome Aberrations (CCGA)
CGC Collaborations
Gene Lists
Educational Resources
Geneticist Toolkit
Meetings & Webinars
CGC Annual Meeting
CGC Webinars and Special Seminars
Coffee Breaks with CGC Mentors
Past CGC Annual Meetings
2024 Annual Meeting Presentations
2023 Annual Meeting Presentations
2022 Annual Meeting Presentations
2021 Annual Meeting Presentations
2020 Annual Meeting Presentations
2019 Annual Meeting Presentations
2019 Select Annual Meeting Presentations
2018 Select Annual Meeting Presentations
Event Calendar
Support the CGC
Support the CGC
2025 CGC Corporate Council
CGC Corporate Council
2025 Annual Meeting Industry Opportunities
Contact
Join
CGC Annual Meeting
Program Highlights
CME / PACE Credit
2025 Keynote Speakers
2025 Invited Speakers
2025 Variant Interpretation Unconference
2025 Pre-Meeting Workshops
2025 Round Table Sessions
2025 Scientific Program
2025 Scientific Program
Scientific Program Overview
Abstract Submission
Abstract Submission
2025 Abstract Awards
Registration
Registration
Resource Limited Nations
Hotel & Transportation
2025 Social Events
Industry Support
Industry Support
2025 Annual Meeting Industry Opportunities
Member Area
×
Member's Area
Forgot Password?
Member's Area
Facebook
LinkedIn
Twitter
Youtube
About
Letter from the President
Leadership
Leadership
Past Leadership
Mission and Goals
The History of CGC
CGC News
Privacy Policy
Membership
Become a Member
Working Groups
Committees
Member Login
Support the CGC
Resources
Cancer Genetics Journal
CGC Publications
CGC Policies and Procedures
Compendium of Cancer Genome Aberrations (CCGA)
CGC Collaborations
Gene Lists
Educational Resources
Geneticist Toolkit
Meetings & Webinars
CGC Annual Meeting
CGC Webinars and Special Seminars
Coffee Breaks with CGC Mentors
Past CGC Annual Meetings
2024 Annual Meeting Presentations
2023 Annual Meeting Presentations
2022 Annual Meeting Presentations
2021 Annual Meeting Presentations
2020 Annual Meeting Presentations
2019 Annual Meeting Presentations
2019 Select Annual Meeting Presentations
2018 Select Annual Meeting Presentations
Event Calendar
Support the CGC
Support the CGC
2025 CGC Corporate Council
CGC Corporate Council
2025 Annual Meeting Industry Opportunities
Contact
Join
Mobile Menu
2024 CGC Meeting Evaluation - Tuesday Morning
Scientific Program Evaluations Program Date: Tuesday, August 6, 2024 Please help us evaluate our speakers and the CGC 2024 Annual Meeting by answering a few questions below. We will have an evaluation form for each session and appreciate your time to give us your feedback. All evaluations are anonymous.
Please note, name and email address are required as part of the attendance verification for P.A.C.E. credit. Please be sure to list your name as it should appear when submitting P.A.C.E. credit.
*
- Required Field
First Name *
Last Name *
Email *
Invited Speaker Presentation: To
a carpenter, every problem is a nail: The FDA brings a hammer to diagnostic medicine
Dara Aisner,
University of Colorado Anschutz Medical Campus
To what extent were the speakers knowledgeable, organized and effective? (Scale of 1-5, 1 being low/poor, 5 being high/excellent)
*
1
2
3
4
5
N/A
To what extent were you satisfied with the program content? (Scale of 1-5, 1 being low/poor, 5 being high/excellent)
*
1
2
3
4
5
N/A
To what extent were the given objectives met? (Scale of 1-5, 1 being low/poor, 5 being high/excellent)
*
1
2
3
4
5
N/A
Reimbursement for molecular pathology testing for neoplasia: The 2024 update
Xiaoyu Qu,
Fred Hutchinson Cancer Center
To what extent was the speaker knowledgeable, organized and effective? (Scale of 1-5, 1 being low/poor, 5 being high/excellent) *
1
2
3
4
5
N/A
To what extent were you satisfied with the program content? (Scale of 1-5, 1 being low/poor, 5 being high/excellent)
*
1
2
3
4
5
N/A
To what extent were the given objectives met? (Scale of 1-5, 1 being low/poor, 5 being high/excellent)
*
1
2
3
4
5
N/A
Current next generation sequencing reporting practices: a GOAL consortium report
Celeste Eno,
Cedars-Sinai Medical Center
To what extent was the speaker knowledgeable, organized and effective? (Scale of 1-5, 1 being low/poor, 5 being high/excellent) *
1
2
3
4
5
N/A
To what extent were you satisfied with the program content? (Scale of 1-5, 1 being low/poor, 5 being high/excellent)
*
1
2
3
4
5
N/A
To what extent were the given objectives met? (Scale of 1-5, 1 being low/poor, 5 being high/excellent)
*
1
2
3
4
5
N/A
A cross-consortia initiative for aligning the definitions and descriptions of gene fusions
Alex Wagner,
Nationwide Children's Hospital
To what extent was the speaker knowledgeable, organized and effective? (Scale of 1-5, 1 being low/poor, 5 being high/excellent) *
1
2
3
4
5
N/A
To what extent were you satisfied with the program content? (Scale of 1-5, 1 being low/poor, 5 being high/excellent)
*
1
2
3
4
5
N/A
To what extent were the given objectives met? (Scale of 1-5, 1 being low/poor, 5 being high/excellent)
*
1
2
3
4
5
N/A
Invited Speaker Presentation: Cell-free DNA and AI technology for liquid biopsy detection of cancer early and prediction of cancer treatment response
Aadel Chaudhuri,
Mayo Clinic
To what extent was the speaker knowledgeable, organized and effective? (Scale of 1-5, 1 being low/poor, 5 being high/excellent) *
1
2
3
4
5
N/A
To what extent were you satisfied with the program content? (Scale of 1-5, 1 being low/poor, 5 being high/excellent)
*
1
2
3
4
5
N/A
To what extent were the given objectives met? (Scale of 1-5, 1 being low/poor, 5 being high/excellent)
*
1
2
3
4
5
N/A
Do you have any comments to share about this session?
Consent:
By submitting your data you give us your consent to process it in accordance with our
Privacy Policy
Submitting Form... (Please do not close your browser)
Saving Form... (Please do not close your browser)